All conditions

ADHD

Plain English clinical trial information, updated daily from ClinicalTrials.gov and public government registries. Not medical advice.

1617
Trials on record
144
Recruiting now
0
Australian sites
10
Phase 3 trials
5
PBS medicines
How these figures are counted
  • Trials on record is every trial tagged to this condition at any stage, except those withdrawn before starting or terminated early. Most are completed rather than ongoing, so this is a measure of research history, not of current activity. It is also smaller than the sitewide "trials tracked" figure, which does include withdrawn and terminated trials.
  • Recruiting now counts only trials whose registry status is "Recruiting". Trials listed as not yet recruiting or enrolling by invitation are excluded, so this understates how many may open to new participants soon.
  • Australian sites counts trials counted under "Recruiting now" that list at least one Australian site. A site being listed does not mean it is currently enrolling, and Australian trials registered only on ANZCTR are not counted yet, so this understates local availability.
  • Phase 3 trials counts trials counted under "Recruiting now" that are at Phase 3.

Find recruiting trials for ADHD →

Get alerts when ADHD trials change ↗

Voxsanity currently covers 103 conditions. We are expanding coverage regularly.

Understanding ADHD

Attention Deficit Hyperactivity Disorder, or ADHD, is a condition that affects how the brain manages attention, impulse control, and activity levels. People with ADHD may find it hard to focus on tasks, act before thinking things through, feel restless, or struggle to organise their day-to-day life. These experiences are not a sign of laziness or low intelligence — they reflect genuine differences in the way the brain works. Symptoms can look different from person to person, and there are a few recognised types, including presentations where attention difficulties are the main feature, where hyperactivity and impulsivity are more prominent, or a combination of both.

ADHD is one of the most common neurodevelopmental conditions in Australia. It affects children and adults across all backgrounds, and it is often identified in childhood, though many people are not diagnosed until adulthood. Australian research suggests roughly one in twenty people are affected, and diagnosis rates have been increasing as awareness and understanding of the condition has improved. It is more frequently diagnosed in males, though females are recognised as being historically underdiagnosed, often because their symptoms can present differently.

Treatment in Australia generally involves a combination of approaches tailored to the individual. These commonly include education about the condition, behavioural strategies, psychological support such as therapy or skills coaching, and in many cases medication prescribed and monitored by a doctor. Schools, workplaces, and support services can also play an important role in helping people manage day-to-day life. A GP or specialist is the right person to talk to about what options might be appropriate for any individual situation.

This overview is an AI generated summary written from public medical sources and checked on a sample basis. It is general information, not medical advice or a diagnosis. Always speak with your doctor about your situation. How we use AI

Can you access treatment for ADHD in Australia right now? Here's what's publicly known.

  • 5 PBS-subsidised medicines are mapped to ADHD on the Pharmaceutical Benefits Scheme, listed below. Your doctor can advise whether a PBS-subsidised option is appropriate for you.
  • No trials currently recruiting at Australian sites right now. Worldwide trials may still be an option. See the trial list below.

Information on this site does not constitute medical advice. Data is sourced from publicly available government registries. Always consult your doctor before making any health decisions. Trial status should be verified directly with the trial site.

Updated regularly from public government registries

PBS-subsidised medicines for ADHD

5 medicines listed on the PBS for ADHD. Filter by authority type, or open the full table below.

What the authority types mean Unrestricted: no clinical criteria; a doctor can prescribe it on the PBS for any appropriate use. Restricted benefit: subsidised only for the specific conditions or uses set out by the PBS. Streamlined authority: restricted, but the doctor does not need prior approval; they record a streamlined authority code confirming you meet the criteria. Authority required: restricted, and the doctor must get prior approval from Services Australia (by phone or online) before it is subsidised. Source: Pharmaceutical Benefits Scheme (pbs.gov.au).
Full PBS medicines table 5 listed

These medicines are listed on the Pharmaceutical Benefits Scheme (PBS) for the specific indications shown. A listing does not mean a medicine is right for you; your doctor decides what is appropriate. Prices shown are the PBS-determined dispensed price. Most patients pay only the standard co-payment, up to AU$25.00 per script (general) or AU$7.70 (concession or Safety Net) in 2026, with the Australian Government subsidising the rest.

Medicine Brand(s) Listed for
Atomoxetine APO-Atomoxetine Attention deficit hyperactivity disorder AU$28.68 Streamlined authority
Dexamfetamine Aspen Pharmacare Australia Pty Ltd Attention deficit hyperactivity disorder AU$5.95 Authority required
Guanfacine Intuniv Attention deficit hyperactivity disorder AU$48.21 Streamlined authority
Lisdexamfetamine Vyvanse Attention deficit hyperactivity disorder AU$24.94 Authority required
Methylphenidate Ritalin LA, Ritalin LA 30 mg (Switzerland), Ritalin LA 30 mg (Switzerland) +8 more Attention deficit hyperactivity disorder AU$16.17 Authority required

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.

Research pipeline

Where trials for ADHD currently sit in the development pipeline. The funnel shape shows how few drugs reach later phases in general; the counts are this condition's actual trial numbers.

Phase success rates are industry-wide historical averages, not predictions for specific trials. Learn how trials work →

Most active research sponsors

Organisations with the most recruiting trials for ADHD.

View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile
View sponsor profile

Where trials are running

Clinical trial sites for ADHD by country. Australia is highlighted.

Showing the top 10 of 29 countries with trial sites.

If you need support right now

Voxsanity is not an emergency or crisis service, and this page is not medical advice. If you or someone else is in immediate danger, call 000. Australian crisis support lines are below. If you are outside Australia, see our helpful links page for support in your country.

  • Lifeline (24/7 crisis support): 13 11 14
  • Beyond Blue: 1300 22 4636
  • 13YARN (Aboriginal & Torres Strait Islander crisis support, 24/7): 13 92 76
  • Suicide Call Back Service: 1300 659 467
  • SANE Australia: 1800 187 263
  • Emergency: 000

Find a service or provider through official directories:

Questions you could bring to a GP or specialist:

  • What are the treatment options for my situation, and what does each involve?
  • Is a clinical trial something worth considering for me, and how would I be assessed for one?
  • What support is available while I wait for an appointment or a decision?

Clinical trials for ADHD

Showing 144 of 144 trials

The plain English eligibility text on each trial below is an AI generated summary of the official criteria, checked on a sample basis. How we use AI

NCT01246765 · Massachusetts General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2033
🇺🇸 US

Who might be able to join this trial: - You are currently pregnant - You are between 18 and 45 years old - You are willing to take part in the study over the phone - You are able to give your agreement to participate after being informed about the study Who may not be able to join: - You have already finished your pre...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02688959 · University of Wisconsin, Madison Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇺🇸 US

Who might be able to join this trial: - People who are currently enrolled as an undergraduate student at the University of Wisconsin-Madison - People who have a documented (officially recorded) diagnosis of ADHD Who may not be able to join: - People who are unable or unwilling to take part in the study's activities an...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02812537 · Hospices Civils de Lyon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2028
🇫🇷 FR

Who might be able to join this trial: - Children and adolescents who are under 16 years old - Children and adolescents who have been brought to an emergency room because of aggressive behaviour, violence, running away, or theft Who may not be able to join: - Children and adolescents who are visiting the emergency room...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT02951754 · Hospital de Clinicas de Porto Alegre Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 December 2032
🇧🇷 BR

Who might be able to join this trial: - People who are White Brazilian of European descent - People who have been diagnosed with ADHD according to a standard set of psychiatric guidelines known as the DSM-IV - People who are considered eligible for treatment with a short-acting form of methylphenidate (a common ADHD me...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT03221244 · University of California, Davis Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 2 September 2026
🇺🇸 US

Who might be able to join this trial: - A parent or teacher rating scale for attention and focus shows significant attention difficulties, scoring at a certain level on a standardised checklist (confirm with trial site for exact score requirements) - A clinical interview shows the child has 4 or more symptoms of inatte...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03420339 · Matthew J O'Brien, PhD, BCBA-D Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 March 2027
🇺🇸 US

**Who might be able to join this trial:** - Children and adolescents aged between 4 years, 0 months and 12 years, 11 months old. - People with a confirmed diagnosis of Attention Deficit/Hyperactivity Disorder (ADHD) — any type is accepted. - People who display disruptive behaviour, which includes at least one of the f...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT03425669 · Lund University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2024
🇸🇪 SE

Who might be able to join this trial: - Children and adolescents who have been diagnosed with ADHD - Children and adolescents who do not have an ADHD diagnosis (as a comparison group) Who may not be able to join: - Children or adolescents with an intellectual disability - Children or adolescents who have been diagnose...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT03781752 · Icahn School of Medicine at Mount Sinai Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 August 2025
🇺🇸 US

Who might be able to join this trial: - Children and teenagers between 6 and 17 years old whose main diagnosis is ADHD Who may not be able to join: - People whose main diagnosis is not ADHD - People who do not want, do not need, or are not healthy enough to take a single dose of methylphenidate (a common ADHD medicati...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT03781765 · Icahn School of Medicine at Mount Sinai Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 25 September 2025
🇺🇸 US

**Who might be able to join this trial:** - Children who are pre-pubescent (at an early stage of physical development, such as Tanner stage 1 or 2) - Children aged 7 to 12 years old (inclusive) - Children whose parent or guardian has signed a consent form, and where the child has also given their agreement to particip...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04216186 · Sherief Abd-Elsalam Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 December 2030
🇪🇬 EG

Who might be able to join this trial: - You have been diagnosed with ADHD (Attention-Deficit/Hyperactivity Disorder) Who may not be able to join: - You have also been diagnosed with Autism - You have also been diagnosed with Anxiety - You have also been diagnosed with Obsessive Compulsive Disorder (OCD) Important: Al...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04219280 · Children's Hospital Medical Center, Cincinnati Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 September 2025
🇺🇸 US

**Who might be able to join this trial:** - You must be willing to follow all study requirements and be available for the full length of the study. - Children and teenagers between the ages of 6 and 17 years old (at the time of signing up) may be eligible. - The child must be able to swallow liquid medication by mouth....

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04279158 · Hospices Civils de Lyon Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 26 November 2031
🇫🇷 FR

Who might be able to join this trial: - You are male or female, aged between 18 and 75 years old (children aged 8–17 may also be eligible for the ADHD group specifically) - You have normal vision, or your vision is corrected (for example, with glasses or contact lenses) - You are covered by social security - You are wi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04421248 · Donald Gilbert, MD, MS, FAAN, FAAP Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 9 February 2026
🇺🇸 US

**Who might be able to join this trial:** - Children of any gender, race, ethnicity, or socioeconomic background - Children currently aged between 8 years 0 months and 12 years, 11 months, and 30 days old - Children who are willing to answer questions about ADHD and related conditions - Children with ADHD who are will...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04526600 · University of California, Davis Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2024
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with ADHD - People who have a history of fidgeting Who may not be able to join: - People who are currently taking medications that affect mood, behaviour, or mental state — except for ADHD stimulant medications — or any medication that can affect h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04532190 · University of Calgary Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇨🇦 CA

Who might be able to join this trial: - You have been diagnosed with ADHD - You are between 9 and 15 years old - You have an IQ score above 80 (confirm with trial site) - You can read, write, and speak English well enough to give your agreement to participate - If you are currently taking medication for ADHD, you have...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04610697 · The Royal Ottawa Mental Health Centre Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 10 February 2026
🇨🇦 CA

**Who might be able to join this trial:** - You are between 18 and 55 years old - You can read and speak English fluently - You are currently staying as an inpatient on the Forensic Treatment Unit **Who may not be able to join:** - You have been diagnosed with an intellectual disability - You have had a traumatic brai...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04627415 · Lehigh University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

**Who might be able to join this trial:** - Children aged 3 to 5 years and 11 months who have clinically significant symptoms of ADHD. - Children who have been assessed by a clinician and found to meet the diagnostic guidelines (DSM-5) for one of the three types of ADHD, based on a clinical interview along with behavio...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT04704687 · Centre Hospitalier Universitaire, Amiens Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 August 2025
🇫🇷 FR

**Who might be able to join this trial:** - Children (boys or girls) aged 7 to 14 years old who are able to participate and cooperate with the study requirements - A parent or legal guardian must agree to take part and sign a consent form, and the child may also need to sign an agreement form depending on their age and...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT04781140 · Supernus Pharmaceuticals, Inc. Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 June 2026
🇺🇸 US

**Who might be able to join this trial:** - Children who are between 4 years 0 months and 5 years 9 months old at the first visit, and are considered generally healthy - A parent or legal guardian must be willing and able to sign a consent form before any study activities begin - Children who have been formally diagno...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT04946253 · University of Pittsburgh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇺🇸 US

**Who might be able to join this trial:** - You work as a primary care doctor or provider at one of up to 24 selected children's healthcare practices in Pennsylvania. - You work at one of the selected practices and your role involves delivering and coordinating mental or behavioral health care (acting as a "care manag...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05034172 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 25 August 2031
🇫🇷 FR

**Who might be able to join this trial:** **Patients with inherited hyperkinetic movement disorders:** - Any person aged 7 or older, male or female, who has been clinically diagnosed with an inherited hyperkinetic movement disorder (a type of condition causing uncontrolled movements that is passed down in families), w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05133804 · University of Haifa Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 July 2025
🇮🇱 IL

**Who might be able to join this trial:** - You have been diagnosed with PTSD (post-traumatic stress disorder) based on recognised medical guidelines - You are currently receiving care at the outpatient clinic at Lev HaSharon Netanya Adult Clinic - You are between 20 and 60 years old - You received your PTSD diagnosis...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05299814 · Milton S. Hershey Medical Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2026
🇺🇸 US

Who might be able to join this trial: - People who are the parent of a child aged 5 to 12 years old who has been diagnosed with ADHD - People whose child shows at least a mild level of Oppositional Defiant Disorder (ODD) symptoms at home, as measured by a specific rating scale called the DBDRS Who may not be able to j...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05354232 · Massachusetts General Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇺🇸 US

Who might be able to join this trial: - Adults aged 18 to 65 years (both men and women) who are being seen as outpatients (not staying overnight in a hospital) - People who have been diagnosed with ADD or ADHD, or who meet the standard medical diagnostic criteria for ADD/ADHD as defined in the DSM-5 (a widely used ment...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05492422 · Florida State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2027
🇺🇸 US

**Who might be able to join this trial:** - Children aged 8 to 12 years old who have been diagnosed with ADHD as their main condition (confirmed through a structured diagnostic interview) - Children whose ADHD symptoms are rated in the clinical or borderline range by both a parent and a teacher, using standard behaviou...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05584059 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
Hong Kong

**Who might be able to join this trial:** - You speak Cantonese and live in Hong Kong - You live together with a child who is between 3 and 9 years old - You are responsible for taking care of that child on a daily basis - You have daily access to an iPhone or Android smartphone - Your child has a physical, development...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05608434 · National Institute of Mental Health (NIMH) Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 June 2028
🇺🇸 US

**Who might be able to join this trial:** - The child must agree to take part (assent), and a parent or guardian must also give their written agreement (consent). - Children of any sex, race, or ethnicity are welcome. - The child must be between 8 and 16 years old (up to but not yet 17). - The child must have a diagno...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05637320 · University of Guelph Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇨🇦 CA

Who might be able to join this trial: - The child must be between 8 and 15 years old and be able to speak and understand English - The parent or guardian must be over 18 years old and be able to speak and understand English - The family must be looking for mental health support related to anxiety, depression, or diffic...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05700539 · Karolinska Institutet Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2025
🇸🇪 SE

**Who might be able to join this trial:** - People who are over 18 years old - People who can read and write in Swedish - People who have access to a computer, tablet, or smartphone with an internet connection - People who have previously been diagnosed with ADHD - People who are currently studying at a university or c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05728840 · Mindmaze SA Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2026
🇨🇭 CH

Who might be able to join this trial: - The stroke must have occurred less than 1 month ago - Testing during a standard brain assessment must show measurable problems with attention - A brain scan (CT or MRI) must confirm a brain injury - The person must be able to give their own consent by signing a form - The person...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05776056 · VA Office of Research and Development Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 6 July 2026
🇺🇸 US

**Who might be able to join this trial:** - People of any gender who are US military veterans between the ages of 18 and 65 years old. - People who are able to make their own decisions and sign consent forms without needing someone else to decide for them. - People who have been diagnosed with PTSD based on a specific...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT05802680 · Francisco Gonzalez-Lima, PhD Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇺🇸 US

Who might be able to join this trial: - You must be 18 years old or older Who may not be able to join: - There are no listed reasons that would prevent someone from joining this trial Important: Always verify eligibility with the trial site directly before applying.

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05832489 · University Hospital, Strasbourg, France Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 May 2027
🇫🇷 FR

Who might be able to join this trial: **Criteria that apply to all participants:** - Adults between 18 and 60 years old (male or female) - People who are covered by a health insurance scheme - People who are able to understand the goals and risks of the study and can give written, dated consent - People who have been...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05842330 · Stéphanie Baggio Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 October 2026
🇨🇭 CH

Who might be able to join this trial: - You are between 18 and 65 years old - You have a good understanding of French - You are expected to remain in prison for approximately 4 months from the time of the eligibility check - You have been diagnosed with ADHD according to standard diagnostic guidelines (DSM-5) - You are...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05872737 · Chinese University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 8 September 2025
Hong Kong

Who might be able to join this trial: - Parents or caregivers who speak Cantonese and live in Hong Kong - People aged 21 years or older - People who are the primary caregiver of a child aged between two and six years old who has been clinically diagnosed with, or is suspected to have, a neurodevelopmental condition (su...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05918991 · Florida International University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 July 2026
🇺🇸 US

Who might be able to join this trial: - The child has been identified by their school district as an English Language Learner at Level 1 through 4. - The child is enrolled in kindergarten or 1st grade during the year the study takes place. - A parent or teacher has reported that the child shows 6 or more signs of atten...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05930886 · Oregon Health and Science University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 August 2025
🇺🇸 US

**Who might be able to join this trial:** - You are an adult parent or caregiver who identifies as Black or Hispanic/Latino - You have a family member between the ages of 6 and 18 who has been suspected of having ADHD and/or difficulty managing their emotions, or you care for or teach someone who fits this description...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05935722 · Örebro University, Sweden Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2026
🇸🇪 SE

Who might be able to join this trial: - Parents who have an intellectual or developmental disability, such as an intellectual disability, ADHD, or autism spectrum disorder - Parents who have at least one child aged 0 to 9 years old living at home, and who have been assessed by social services as eligible for tailored p...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT05957055 · Medical University of Lodz Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 December 2027
🇵🇱 PL

**Who might be able to join this trial:** - Be between 8 and 16.5 years old at the time of joining the study - Have been diagnosed with Type 1 diabetes (T1D) based on blood sugar tests, specific diabetes-related antibodies in the blood, and/or low levels of a substance called C-peptide - Have had Type 1 diabetes for a...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT05997680 · Anne Gallagher Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2025
🇨🇦 CA

**Who might be able to join this trial:** - The child has been diagnosed with congenital heart disease (a heart condition present from birth) and has had or needs heart surgery - The child is between 4 and 6 years old - The child shows lower-than-average attention skills, as measured by a specific attention test called...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06010966 · First Affiliated Hospital of Zhejiang University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2025
🇨🇳 CN

**Who might be able to join this trial:** - People who have been clinically diagnosed with ADHD according to the DSM-5 diagnostic guidelines - Children aged 6 to 12 years old, of any gender - Children who are right-handed - Children of Han nationality, or children born within a Han nationality community - Children who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06012903 · University Hospital, Ghent Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 6 June 2025
🇧🇪 BE

Who might be able to join this trial: - Children who are in 4th, 5th, or 6th grade - Parents who have a child in grades 1 through 6 - Teachers who teach children in grades 1 through 6 - Children who attend a regular primary school - People who can speak and understand Dutch Who may not be able to join: - Students who...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06073470 · National Taiwan University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2027
🇹🇼 TW

Who might be able to join this trial: **For participants with ADHD:** - Children or teenagers between 6 and 18 years old who have been diagnosed with ADHD according to standard diagnostic guidelines (DSM-5) - At the start of the study, participants must have an ADHD severity rating score above 4, as measured by a stan...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06076967 · University of Alabama, Tuscaloosa Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 May 2026
🇺🇸 US

Who might be able to join this trial: - People who are in their first semester of college and have been diagnosed with ADHD - People between the ages of 17 and 25 - People whose ADHD symptoms meet the criteria required by the trial - People who do not have major medical problems Who may not be able to join: - People w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06109337 · First Affiliated Hospital of Zhejiang University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇨🇳 CN

Who might be able to join this trial: - You or your child has been diagnosed with ADHD (Attention Deficit Hyperactivity Disorder) - The child has an IQ score of 70 or above - Both of the child's parents are of Han Chinese ethnicity - The family agrees to allow a blood sample to be taken from a vein and has given writte...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06115603 · University of Arkansas, Fayetteville Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 July 2026
🇺🇸 US

**Who might be able to join this trial:** - You are between 18 and 55 years old - Your body mass index (BMI) is between 18 and 35 (a measure of body weight relative to height) - You scored 4 or above on a standard ADHD self-report questionnaire called the ASRS-v1.1 Part A - You have been assessed and meet the recognise...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06123741 · Merja Nikula Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇫🇮 FI

Who might be able to join this trial: - People who have been diagnosed with ADHD (a specific diagnosis using the international medical coding system) - People who are currently taking methylphenidate medication (a common ADHD medication) - Children who are between 8 and 12 years old - Children whose native language is...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06133231 · Oregon Health and Science University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2025
🇺🇸 US

Who might be able to join this trial: - Children between the ages of 6 and 17 years old at the time of enrollment who have suspected or confirmed ADHD based on parent report - Children whose symptoms meet a certain threshold on a standard ADHD checklist (called the CASI-5), occurring in more than one setting, and who a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06180681 · University of California, San Diego Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇺🇸 US

**Who might be able to join this trial:** - Children aged 7 to 11 years (in 2nd through 5th grade) who attend a school that is taking part in the study - Children who have been referred by a school mental health provider because of concerns related to ADHD - Children who show six or more ADHD-related symptoms (either i...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06194162 · University Hospital Bispebjerg and Frederiksberg Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 April 2026
🇩🇰 DK

**Who might be able to join this trial:** - You (or your child's guardian) have agreed to take part by signing a consent form - The child is between 5 and 12 years old (inclusive) at the time of joining the trial - The child has been diagnosed with ADHD using specific recognised diagnostic codes (confirm with trial sit...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06194994 · University of Iceland Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
Iceland

Who might be able to join this trial: - The child has been diagnosed with Oppositional Defiant Disorder (ODD). - Both the child and their parent or guardian speak Icelandic. Who may not be able to join: - The child has an IQ score below 70 (based on a full scale IQ test). Important: Always verify eligibility with the...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06221358 · University of Calgary Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2028
🇨🇦 CA

Who might be able to join this trial: - People aged 6 to 24 years old. - People living in Western Canada (Alberta, British Columbia, Saskatchewan, or Manitoba). - People who have been diagnosed with ADHD (any type). - People who are starting treatment with a form of Methylphenidate that is not the immediate-release ver...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06232226 · Nantes University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇫🇷 FR

**Who might be able to join this trial:** - You are 18 years old or older - You have been diagnosed with ADHD (Attention Deficit Hyperactivity Disorder) within the last 12 weeks - You have also been diagnosed with at least one addiction problem, such as a substance use disorder (e.g., alcohol, drugs) or a behavioural a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06241300 · University of Illinois at Chicago Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2028
🇺🇸 US

**Who might be able to join this trial:** - The child must be between 4 years old and 5 years, 11 months old - The parent taking part must be the child's legal guardian and live with the child full-time - The parent must be 18 years old or older (there is no upper age limit for parents) - Only one child and one parent...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06248229 · Rochester Center for Behavioral Medicine Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 September 2026
🇺🇸 US

**Who might be able to join this trial:** - People who scored above 3 on both the severity and interference sections of a fatigue questionnaire called the Fatigue Symptom Inventory at their screening visit. - People who scored above 36 on a standard ADHD rating scale (ADHD-RS-IV) at their screening visit. - People who...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06298136 · The Hong Kong Polytechnic University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
Hong Kong

**Who might be able to join this trial:** - Parents of children who have been diagnosed with ADHD by both a psychiatrist and a psychologist, using the DSM-5 (a standard diagnostic guide used by mental health professionals) - Parents of children with ADHD who are between 6 and 12 years old - Parents who have been the ma...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06299189 · Haukeland University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇳🇴 NO

Who might be able to join this trial: - People who are 18 years of age or older - People who have been diagnosed with ADHD (based on their own report of that diagnosis) - People who have access to and are able to use a computer, smartphone, and the internet - People who can speak, write, and read Norwegian Who may not...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06305429 · D'Or Institute for Research and Education Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2025
🇧🇷 BR

Who might be able to join this trial: - People who are parents of children between 4 and 10 years old - Parents who report having difficulty with their child's behaviour during daily transition routines (such as moving from one activity to another) Who may not be able to join: - Parents whose child does not live with...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06325813 · Children's Hospital Medical Center, Cincinnati Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2027
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with ADHD - People who are between 12 and 17 years old - People who take stimulant medication for ADHD may still be considered, as long as the medication is stopped 24 hours before and on the days of the TMS treatment visits Who may not be able to...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06350292 · University of South Florida Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2025
🇺🇸 US

**Who might be able to join this trial:** - Children aged 8 to 12 who have previously been diagnosed with Oppositional Defiant Disorder (ODD) and also have trouble sleeping - Both the child and their parent or guardian are comfortable speaking and reading English - The child has had difficulty falling asleep, staying...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06369714 · Lei Lei, MD Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2025
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with ADHD according to the standard diagnostic guidelines used by mental health professionals (called the DSM-5). - People who scored below 50 points on a specific attention test called the Digital Cancellation Test. - People who scored 85 or above...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06373484 · Centre for Addiction and Mental Health Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇨🇦 CA

**Who might be able to join this trial:** - The child scores at a borderline or concerning level on a standard behaviour checklist filled out by a parent or teacher, showing higher-than-usual levels of difficult or defiant behaviour (confirm with trial site for exact score details) - The child has significant difficul...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06376331 · The Second Hospital of Nanjing Medical University Phase 1 · 1 country Recruiting
Recruiting Phase 1 Est. completion 1 June 2027
🇨🇳 CN

**Who might be able to join this trial:** - Children who have been officially diagnosed with ADHD based on standard diagnostic guidelines (DSM-5) - Children between the ages of 3 and 17 - Children who have been on a stable treatment plan for at least 1 month before the trial procedure begins - Children who have not tak...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06378281 · Stéphanie Baggio Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇨🇭 CH

Who might be able to join this trial: - You must already be taking part in the related main ("parent") clinical trial - You must be 18 years old or older - You must have a good understanding of the French language - You must not currently have an acute (sudden or severe) psychiatric disorder - You must have already sig...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06410495 · University of South Florida Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2025
🇺🇸 US

**Who might be able to join this trial:** - Children aged 8 to 17 who have already been diagnosed with Oppositional Defiant Disorder (ODD) and also have trouble sleeping - Both the child and their parent or guardian are able to communicate in English - The child has had problems falling asleep, staying asleep, or waki...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06446284 · Hartford Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with ADHD - People who speak English - People who are right-handed - People whose reading ability is above a 5th grade level - People whose IQ score is above 80 Who may not be able to join: - People who have braces, metal implants, or other metal d...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06456372 · University of California, Riverside Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 29 September 2027
🇺🇸 US

Who might be able to join this trial: - People who have already been diagnosed with ADHD by a doctor or psychologist, based on DSM-5TR criteria, at the time they enter the program. - People who are able to complete questionnaires and use a smartphone app in English. - People with a reported IQ of at least 80, to help e...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06512974 · NeuroTrainer Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2026
🇺🇸 US

Who might be able to join this trial: - You have been diagnosed with ADHD of any type, with symptoms ranging from mild (just below the threshold) to moderate or severe - You have an estimated IQ of 80 or above - You are between 11 and 17 years old Who may not be able to join: - You are currently having thoughts of sui...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06540547 · University of Pittsburgh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2026
🇺🇸 US

**Who might be able to join this trial:** - People who have been diagnosed with ADHD meeting the full set of criteria outlined in the DSM-5 (the standard medical handbook used to diagnose mental health conditions) - People who are between 20 and 32 weeks pregnant at the time of joining - People who speak English - Peop...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06542445 · Bazelet Nehushtan LtD. Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 22 August 2026
🇮🇱 IL

**Who might be able to join this trial:** - Children and teenagers between 6 and 18 years old who have been diagnosed with ADHD by a neurologist, psychiatrist, or other specialist, using the DSM-V diagnostic guidelines - People who are able and willing to attend all required visits as set out in the study plan **Who m...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06553430 · Harbin Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2024
🇨🇳 CN

Who might be able to join this trial: - The child has been clinically diagnosed with ADHD - The child is between 7 and 14 years old - The child has scored 80 or above on a standard cognitive ability test called the Combined Raven's Test - The child is not currently receiving any other form of treatment apart from medic...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06577779 · NYU Langone Health Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 30 June 2026
🇺🇸 US

**Who might be able to join this trial:** - You are between 18 and 60 years old (inclusive) - You are able to read and sign a consent form agreeing to take part - You are of any gender - You have been officially diagnosed with ADHD (specifically the inattentive or combined type), confirmed through a structured clinica...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06632249 · Hospital de Clinicas de Porto Alegre Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2026
🇧🇷 BR

Who might be able to join this trial: - People who have been diagnosed with ADHD according to the DSM-5 diagnostic guidelines - People aged between 12 and 17 years old - People who have either never taken ADHD medication, or who have not taken ADHD medication for at least one month Who may not be able to join: - Peopl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06639139 · Hebrew University of Jerusalem Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 October 2025
🇮🇱 IL

Who might be able to join this trial: - You have been diagnosed with ADHD (Attention Deficit Hyperactivity Disorder) and are willing to confirm this yourself Who may not be able to join: - You have another serious health condition (physical or mental) that makes it difficult for you to carry out everyday activities I...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06655610 · Psychiatric Research Unit, Region Zealand, Denmark Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2026
🇩🇰 DK

**Who might be able to join this trial:** - You are between 7 and 17 years old at the time of joining the study. - You have been diagnosed with ADHD by a doctor, confirmed using standard diagnostic tools and interviews. - Your ADHD symptoms score above a certain level on a standard rating scale at the start of the stud...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06682949 · Cori Manning Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2025
🇺🇸 US

Who might be able to join this trial: - People who have been clinically diagnosed with attention-deficit/hyperactivity disorder (ADHD) - People who live in or near the Tucson, Arizona area - People who have a guardian who is willing to take part in the trial alongside them Who may not be able to join: - People who hav...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06685601 · Qilu Hospital of Shandong University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2026
🇨🇳 CN

**Who might be able to join this trial:** - You are between 6 and 18 years old - A psychiatrist has clinically diagnosed you with ADHD - A child psychiatrist has confirmed your ADHD diagnosis meets the official DSM-5 diagnostic guidelines - A structured interview called the M.I.N.I. KID shows that you have ADHD only, w...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06703242 · Adina Maeir Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2025
🇮🇱 IL

Who might be able to join this trial: - You are a mother of a child who has been diagnosed with ADHD and is between 6 and 12 years old - You identify as an ultra-orthodox Jewish woman - Your child's ADHD diagnosis was made by a licensed medical professional Who may not be able to join: - Your child has a medical diagn...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06725186 · Virginia Polytechnic Institute and State University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2027
🇺🇸 US

Who might be able to join this trial: - The child has a diagnosis of ADHD and is currently in middle school or high school. - The child has a verbal IQ score of 80 or above, as measured by a standard intelligence test called the Wechsler Intelligence Scale for Children, Fifth Edition. - The child does not have a severe...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06728969 · MindTension Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2026
🇺🇸 US

Who might be able to join this trial: - A parent or guardian must sign and date a consent form on behalf of their child - The child must be willing to follow all study procedures and be available for the full length of the study - Children of any gender aged 6 to 17 years old - Children who have never taken stimulant m...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06743425 · IDeA States Pediatric Clinical Trials Network Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 26 March 2026
🇺🇸 US

**Who might be able to join this trial:** **Regarding the child:** - The child must be under the care of a healthcare provider who is participating in this trial - The child must be between 5 and 11 years old at the time of joining - The child must have a diagnosis of ADHD - The child must be either starting stimulant...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06797726 · University Hospital, Tours Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 August 2026
🇫🇷 FR

**Who might be able to join this trial:** - You are 18 years of age or older - You are receiving treatment at an outpatient addiction department at the University Hospital of Brest, Nantes, or Tours, and you have been diagnosed with both ADHD and a behavioural addiction - You are enrolled in the French social security...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06808425 · Halmstad University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2034
🇸🇪 SE

**Who might be able to join this trial:** - Children who have been diagnosed with ADHD according to standard diagnostic guidelines (known as DSM-5) and who also have sleep problems identified through a screening tool. - Children who are currently receiving care at a child and adolescent mental health service (CAMHS) in...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06831123 · University of Minnesota Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 28 February 2027
🇺🇸 US

Who might be able to join this trial: - Students currently in 9th or 10th grade at a school that is partnering with this trial - Students who have been identified through a standardised screening tool as having elevated social or emotional concerns, or who have been referred by school staff due to concerns about behavi...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06847165 · University of California, Los Angeles Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2026
🇺🇸 US

**Who might be able to join this trial:** - Your child has been diagnosed with Fetal Alcohol Syndrome, Partial Fetal Alcohol Syndrome, or Alcohol-Related Neurodevelopmental Disorder, meaning their mother drank alcohol during pregnancy (certain facial features are not required for this diagnosis) - The mother drank mor...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06848959 · Yun Liu,PhD Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 28 February 2025
🇨🇳 CN

Who might be able to join this trial: - You have been diagnosed with one or more of the following conditions: Cerebral Palsy (CP), Intellectual Disability (ID), Typical Development (TD), Attention Deficit Hyperactivity Disorder (ADHD), or Autism Spectrum Disorder (ASD) (confirm with trial site) - Both males and females...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06858527 · Assistance Publique - Hôpitaux de Paris Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2029
🇫🇷 FR

**Who might be able to join this trial:** - People aged 18 or older - People who have been diagnosed with at least one moderate to severe substance use disorder (not including tobacco) according to standard diagnostic criteria (DSM-5) - People who are currently receiving treatment for a substance use disorder from a do...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06860763 · The Third Affiliated Hospital of Beijing University of Chinese Medicin... Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 15 October 2026
🇨🇳 CN

**Who might be able to join this trial:** - Children who have been officially diagnosed with ADHD according to standard diagnostic guidelines (DSM-5) and relevant Traditional Chinese Medicine guidelines - Children aged between 6 and 12 years old - Children who have not taken any medications — including Western medicine...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06871488 · Milton S. Hershey Medical Center Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 28 February 2030
🇺🇸 US

**Who might be able to join this trial:** - Children who have been diagnosed with ADHD, in any form - Children whose ADHD causes moderate or significant difficulties in daily life - Children who show higher-than-usual levels of irritability and/or aggression, as rated by a parent or guardian using specific assessment t...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT06900400 · IRCCS Eugenio Medea Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 May 2026
🇮🇹 IT

Who might be able to join this trial: **ADHD Group:** - People who have been diagnosed with ADHD, of any type or severity level - People with ADHD who have never been prescribed or started any medication specifically for ADHD - People with ADHD who have an IQ score of 70 or above **Non-ADHD Comparison Group:** - Peop...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06902649 · Karolinska Institutet Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2027
🇸🇪 SE

Who might be able to join this trial: - Families with children aged 8 to 16 years who have trouble controlling anger, or who show defiant or aggressive behaviour, where the child meets a specific number of recognised diagnostic markers for either Oppositional Defiant Disorder (at least 3 markers) or Conduct Disorder in...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06910605 · Stefan Lakämper Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2026
🇨🇭 CH

**Who might be able to join this trial:** - Adults who hold a driver's licence and drive regularly - People who have been diagnosed with ADHD and are treated with stimulant medication only (not other types of ADHD medication) - People who have a known history of taking planned breaks from their ADHD medication by their...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06926829 · Otsuka Pharmaceutical Co., Ltd. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 December 2027
🇯🇵 JP

**Who might be able to join this trial:** - You must have completed the full treatment and follow-up period of the earlier related study (Trial 405-102-00112) without being asked to stop taking the study medication early. - You must have followed the rules of the earlier study well, including taking the study medicatio...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06931080 · Otsuka Pharmaceutical Co., Ltd. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 December 2027
🇯🇵 JP

**Who might be able to join this trial:** - You have been diagnosed with ADHD (a specific type, not "other" or "unspecified" ADHD) based on a structured diagnostic interview using recognised criteria (DSM-5). - If you are **not** currently taking ADHD medication, your ADHD symptom score on a standard rating scale must...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06960980 · Children's Hospital Medical Center, Cincinnati Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2029
🇺🇸 US

Who might be able to join this trial: - People aged 16 to 19 years old. - Teens who have been diagnosed with ADHD — either the mainly inattentive type or the combined type — confirmed through a structured interview called the K-SADS. - People who hold a valid driver's licence and spend at least 3 hours per week driving...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06967857 · Prof. Dr. Frank Behrens Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 December 2026
🇩🇪 DE

**Who might be able to join this trial:** - People who have been diagnosed with ADHD (according to recognised medical guidelines) where symptoms began before the age of 12 - People whose ADHD symptoms score at least 32 on a specific ADHD checklist used at the first study visit - People who have moderate to severe depr...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT06971640 · Duke University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2029
🇺🇸 US

Who might be able to join this trial: - Children between the ages of 6 and 9 - Children who have been diagnosed with ADHD (any type) according to standard psychiatric guidelines (DSM-5) - Children whose general intellectual ability scores above 80, as measured by standard testing - Children who are generally healthy wi...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06974136 · The National Brain Mapping Laboratory (NBML) Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
Iran

**Who might be able to join this trial:** - You or your child has been diagnosed with ADHD by a licensed psychiatrist, confirmed with a behavioral checklist - The child is between 7 and 18 years old - Parents or guardians are willing and able to sign a written consent form on behalf of their child **Who may not be abl...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06978452 · Douglas Mental Health University Institute Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 July 2029
🇨🇦 CA

**Who might be able to join this trial:** - You are between 9 and 25 years old at the time of joining - You are able to read and understand either French or English - If you are under 18, at least one parent or legal guardian is available to give permission for you to take part - You have reached out at least once to a...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT06984809 · University of Tromso Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2028
🇳🇴 NO

Who might be able to join this trial: - You are a parent of a child between 6 and 12 years old who has been referred to an outpatient clinic for help with behavioural problems. - Your child scores above a certain threshold on a standard behavioural checklist (called the Eyberg Child Behavior Inventory), based on your r...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07001293 · University of Pittsburgh Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2028
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with ADHD according to the full DSM-5 diagnostic criteria - People who are between 14 and 22 weeks pregnant at the time of joining - People who are 18 years of age or older - People who speak English - People who live in Pennsylvania Who may not be...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07042347 · University of Pennsylvania Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2028
🇺🇸 US

**Who might be able to join this trial:** - Aides (support workers) who are currently working one-on-one with at least one child or young person in a school setting, where that child is between 3 and 17 years old, has a diagnosis linked to challenging behaviour (such as autism spectrum disorder, ADHD, or oppositional...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07084324 · University of Colorado, Denver Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2029
🇺🇸 US

Who might be able to join this trial: - The child is between 8 and 11 years old. - The child has been diagnosed with Autism Spectrum Disorder (ASD) and/or ADHD based on standard diagnostic guidelines. - The child has verbal (speaking and language) skills at the level of a typical 7-year-old or above, as measured by a s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07084649 · Shanghai Mental Health Center Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 1 September 2026
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with ADHD according to the DSM-5 (the standard medical guide used to diagnose mental health conditions) - People whose ADHD symptoms have not improved enough after completing a full course of medication treatment, based on specific rating scale scor...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07086313 · Otsuka Pharmaceutical Co., Ltd. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 August 2027
🇯🇵 JP

**Who might be able to join this trial:** - You have been officially diagnosed with ADHD (and not a vague or unclear form of it) based on standard diagnostic guidelines, confirmed through a structured interview. - Your ADHD symptoms score at least 28 out of a possible total on a standard rating scale at the start of t...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07087327 · Otsuka Pharmaceutical Co., Ltd. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 1 August 2027
🇯🇵 JP

**Who might be able to join this trial:** *For people transferring from the earlier related trial (called "rollover participants"):* - People who completed the full 6-week treatment period and the 1-week follow-up in the earlier related trial, and who were not asked to stop taking the trial medication at the 6-week ma...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07089745 · Duke University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2026
🇺🇸 US

Who might be able to join this trial: - You are a young person between the ages of 13 and 17 years old - You have already been diagnosed with ADHD, and this is recorded in your medical notes - You are currently seeking treatment at the Duke ADHD Program Who may not be able to join: - You have another mental health con...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07091721 · Anna Freud Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2027
🇬🇧 GB

**Who might be able to join this trial:** - The child must be between 10 and 17 years old at the time of referral - There must be concerns about aggression and/or violence noted at referral or during assessment - Taking part in the study must not interfere with any legal or court-ordered requirements the child has - B...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07105475 · Ben-Gurion University of the Negev Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇮🇱 IL

**Who might be able to join this trial:** - Adults between the ages of 21 and 65 (men and women). - People who have been diagnosed with ADHD according to the DSM-5 diagnostic guidelines. - People currently taking ADHD medication who are willing to switch to a short-acting form of Ritalin (10mg, with the possibility of...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07111169 · University of Electronic Science and Technology of China Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 December 2028
🇨🇳 CN

**Who might be able to join this trial:** - You are between 18 and 55 years old - You are right-handed - You have normal vision, or your vision is fully corrected (for example, with glasses or contact lenses) - You have been diagnosed with Major Depressive Disorder (MDD) according to standard criteria, and are either n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07136636 · Semmelweis University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇭🇺 HU

Who might be able to join this trial: - The child must have been born between 2017 and 2023 with moderate to severe lack of oxygen to the brain around the time of birth (HIE), and received cooling treatment at Semmelweis University Children's Hospital - The child must have been born at 35 weeks of pregnancy or later (n...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07147894 · Northeastern University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2028
🇺🇸 US

**Who might be able to join this trial:** - Children aged 12 to 17 years old. - The child must have a parent or guardian who is available to take part in the trial as a helper during training. - Both the child and their parent or guardian must be able to understand and speak enough English or Spanish to take part in t...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07162831 · Insel Gruppe AG, University Hospital Bern Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 August 2027
🇨🇭 CH

Who might be able to join this trial: - The participant (and/or a parent or legal guardian) must have signed a consent form agreeing to take part - Children and young people aged 8 to 16 years old - People who have been diagnosed with ADHD, whether mild, moderate, or severe - People with an IQ score above 85, as measur...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07169760 · Rutgers, The State University of New Jersey Phase 4 · 1 country Recruiting
Recruiting Phase 4 Est. completion 1 September 2030
🇺🇸 US

**Who might be able to join this trial:** - You have been diagnosed with ADHD according to standard diagnostic guidelines (DSM-5) - You are between 18 and 25 years old - You experience significant attention and focus difficulties specifically related to homework tasks, based on a screening questionnaire score (confirm...

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
NCT07180758 · Biruni University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2025
Turkey (Türkiye)

Who might be able to join this trial: - Students who attend a middle school in the Eyüpsultan district - Students whose parents have given written agreement for their child to take part - Students who are enrolled in full-time education - Children whose physical movement and motor skills are developing as expected for...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07189442 · Texas Tech University Health Sciences Center Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇺🇸 US

**Who might be able to join this trial:** - You are 18 years old or older - A doctor has diagnosed you with ADHD or ASD (based on what you report) - If you have been diagnosed with both ADHD and ASD, you may still participate, but you would be placed in the ASD group for the purposes of the study **Who may not be able...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07203092 · Francisco Gonzalez-Lima, PhD Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2027
🇺🇸 US

Who might be able to join this trial: - People who speak English - Adults of any sex aged between 18 and 44 years - People from any ethnic or racial background - People who have a medical history of ADHD - People who are either not taking ADHD medication, or who have been on a stable ADHD medication routine with no cha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07214545 · University of California, San Francisco Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2027
🇺🇸 US

**Who might be able to join this trial:** - You (or your child) must have a confirmed diagnosis of Autism Spectrum Disorder (ASD), backed up by a specific standardised assessment test. - You (or your child) must have an IQ score above 70, confirmed through a recognised intelligence test. - You (or your child) must also...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07219810 · Bradley Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 September 2029
🇺🇸 US

**Who might be able to join this trial:** - You are between 12 and 18 years old - Both you and your parent/guardian speak English well enough to understand and agree to take part in the study - You have been formally diagnosed with ADHD, confirmed through a structured interview used by the research team - Your parent/...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07256704 · Luzerner Kantonsspital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2029
🇨🇭 CH

Who might be able to join this trial: - People who have been diagnosed with a stroke, traumatic brain injury (TBI), or multiple sclerosis (MS) - People who are receiving care as an inpatient or outpatient at the Clinic for Neurology and Neurorehabilitation - People aged 18 years or older - People who understand the Ger...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07262853 · Education University of Hong Kong Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 June 2026
Hong Kong

Who might be able to join this trial: - Children who are between 6 and 11 years old - Children who are currently attending a primary school in Hong Kong - Children who have been diagnosed with, or are suspected to have, ADHD (Attention Deficit Hyperactivity Disorder), ASD (Autism Spectrum Disorder), or SpLD (a specific...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07273695 · IRCCS Eugenio Medea Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2026
🇮🇹 IT

**Who might be able to join this trial:** - Children and teenagers between the ages of 8 and 15 years old - People who have been diagnosed with behavioral difficulties, ADHD, and/or problems with managing emotions (identified through questionnaires, interviews, and/or professional observation) - People who have an IQ s...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07281092 · Seattle Children's Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2026
🇺🇸 US

Who might be able to join this trial: - People who are between 13 and 17 years old - People who have an existing diagnosis of ADHD recorded in their medical history - People who are seeking treatment at the Seattle Children's Hospital BAM Clinic Who may not be able to join: - People who have another mental health cond...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07291453 · Okinawa Institute of Science and Technology Graduate University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2026
🇯🇵 JP

Who might be able to join this trial: - You are a parent with a child between the ages of 4 and 10 who has difficulties in certain situations that the program is designed to address. - Your child does not need to have a formal diagnosis of ADHD or be showing high levels of ADHD-related behaviour to take part — the prog...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07363551 · China Medical University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2026
🇹🇼 TW

Who might be able to join this trial: - Young people who have been diagnosed with Major Depressive Episode (a serious period of depression) according to standard medical guidelines known as DSM-5 Who may not be able to join: - People who have had a change to their antidepressant medication or talking therapy (such as...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07364331 · China Medical University Hospital Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 July 2026
🇹🇼 TW

Who might be able to join this trial: - You have been officially diagnosed with ADHD according to current diagnostic standards (DSM-5) - Your ADHD treatment (whether medication or therapy) has not changed in the 4 weeks before joining the trial - Your ADHD symptoms (inattention and/or hyperactivity) score at a certain...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07380412 · Outliers, Inc. Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2026
🇺🇸 US

**Who might be able to join this trial:** - You are between 18 and 55 years old - You are currently taking a prescribed stimulant medication for ADHD - You are experiencing some of the following: trouble sleeping, irritability, anxiety, or mental fogginess ("brain fog") - Your ADHD medication dose has stayed the same f...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07456631 · University of Coimbra Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 September 2027
🇵🇹 PT

Who might be able to join this trial: - (Study I) You have been given a main diagnosis of Oppositional Defiant Disorder (ODD) and also meet the criteria for Social Anxiety Disorder (SAD) - (Study II) You have been given a main diagnosis of Social Anxiety Disorder (SAD) and also meet the criteria for Oppositional Defian...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07459699 · Probi AB Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 December 2027
🇨🇳 CN

Who might be able to join this trial: - Children aged 8 to 11 years old, either male or female - Children who have mild ADHD symptoms - Children whose parents or legal guardians are willing and able to follow the study procedures and take part in the research alongside the child Who may not be able to join: - Children...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07466147 · University of Tartu Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 February 2027
🇪🇪 EE

**Who might be able to join this trial:** - The child is between 5 and 12 years old - The child has been diagnosed with or is experiencing ADHD, autism spectrum disorder (ASD), difficulties managing behaviour, and/or difficulties fitting in or adapting in group settings - The child is currently receiving physiotherapy...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07469215 · Fundació Sant Joan de Déu Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇪🇸 ES

Who might be able to join this trial: - People who are the main caregiver for a child aged 5 to 12 years who shows disruptive behaviour, such as problems with defiance, conduct, impulse control, attention, or other behavioural difficulties - People who have access to an electronic device (such as a phone, tablet, or co...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07478458 · Istituto Giannina Gaslini Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 January 2028
🇮🇹 IT

**Who might be able to join this trial:** **For the ADHD group:** - Adolescents between the ages of 13 and 18 (up to but not yet 19 years old) - People who have been diagnosed with ADHD (any type: hyperactive, inattentive, or combined) - People who agree to take part, or in the case of someone under the legal age of c...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07504107 · Universiteit Leiden Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 March 2028
🇳🇱 NL

**Who might be able to join this trial:** - You are between 16 and 25 years old. - You have an official ADHD diagnosis, which the research team will confirm using a structured clinical interview. - You have low self-esteem related to your ADHD, which is checked through a step-by-step process: a referral from a clinici...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07552909 · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 May 2026
🇨🇳 CN

Who might be able to join this trial: - Children who are between 7 years old and 11 years and 11 months old - Children who have been officially diagnosed with ADHD by a qualified child psychiatrist - Children who scored above 85 on a standard IQ test called the Wechsler Intelligence Scale for Children - Children who ha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07565402 · Nanjing Medical University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 21 June 2028
🇨🇳 CN

Who might be able to join this trial: - People who have been diagnosed with ADHD (Attention-Deficit/Hyperactivity Disorder) based on standard diagnostic guidelines (DSM-5), confirmed through a structured interview tool called the DIVA-5 (Chinese version). - People aged between 18 and 55 years. - People who are right-ha...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07592390 · Universidade do Sul de Santa Catarina Phase 2 · 1 country Recruiting
Recruiting Phase 2 Est. completion 18 December 2026
🇧🇷 BR

**Who might be able to join this trial:** - You are a teenager between 12 and 17 years old - You have been diagnosed with ADHD, confirmed using a specific standard questionnaire called the SNAP-IV - You have previously tried treatments for ADHD (either medication or other types of therapy) but did not see significant i...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07595783 · Bielefeld University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 October 2026
🇩🇪 DE

**Who might be able to join this trial:** - Children who are between 6 and 13 years old - Children who have been officially diagnosed with ADHD - Children who speak German and have normal vision or vision that is fully corrected with glasses or contact lenses **Who may not be able to join:** - Children who have a neur...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07597707 · University of Calgary Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 31 December 2026
🇨🇦 CA

Who might be able to join this trial: - People who were assigned female at birth, or who identify as a girl or woman - People who are fluent in English or French - People who are 10 years of age or older - People who currently live in Canada - People who have access to a device or technology needed to complete the stud...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07614867 · Karolinska Institutet Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 June 2029
🇸🇪 SE

Who might be able to join this trial: - You have been diagnosed with ADHD based on standard diagnostic guidelines (DSM criteria) - You are 18 years old or older - You have identified difficulties managing or regulating your emotions Who may not be able to join: - You have a diagnosis of intellectual disability - You h...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07634809 · Umeå University Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 November 2028
🇸🇪 SE

Who might be able to join this trial: - Children and teenagers between the ages of 6 and 17 - People who have been diagnosed with ADHD and whose family has agreed to medication being given in line with the clinic's procedures Who may not be able to join: - People who have a diagnosis of an irregular heartbeat (arrhyth...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07654205 · Traci Kennedy Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 1 March 2027
🇺🇸 US

Who might be able to join this trial: - People who are between 18 and 25 years old - People who have been diagnosed with a specific type of ADHD (called Combined Type) based on standard psychiatric guidelines (DSM-5) - People who drink at least 4 alcoholic drinks in one sitting (for females) or at least 5 alcoholic dri...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07665658 · Khyber Medical University Peshawar Not Applicable · 1 country Recruiting
Recruiting Not Applicable Est. completion 30 November 2026
🇵🇰 PK

Who might be able to join this trial: - People with a confirmed ADHD diagnosis based on DSM-5 criteria (a standard set of guidelines doctors use to diagnose ADHD) - Children between the ages of 6 and 12 years old - Children who are either not taking any ADHD medication, or who have been on a stable dose of stimulant me...

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
NCT07717879 · Axsome Therapeutics, Inc. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 June 2028
🇺🇸 US

Who might be able to join this trial: - Children aged 6 up to (but not including) 12 years old, either male or female - Children who have been formally diagnosed with ADHD based on a specific set of medical guidelines called DSM-5 - Children whose parents or legal guardians have given written consent to participate, an...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
NCT07717892 · Axsome Therapeutics, Inc. Phase 3 · 1 country Recruiting
Recruiting Phase 3 Est. completion 30 June 2028
🇺🇸 US

Who might be able to join this trial: - People who are male or female, aged 12 to under 18 years old. - People who have been diagnosed with ADHD based on a specific set of standard medical guidelines called DSM-5. - People whose parents or legal guardians have given written permission for participation, and who have th...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Advocacy and support in Australia

Organisations that can offer information, support, or connection for ADHD. Where more than one is listed, they serve different needs or regions, so choose whichever fits your situation.

ADHD Australia is the go-to national body for advocacy and information on ADHD.

This is a starting point, not medical advice or an endorsement. Contact details change; search the organisation name to find its current website.